Model
Edge
Five Prime Therapeutics, Inc.
0001175505
Filing type
8-K
Filing date
Apr 15, 2021
Updated
Apr 16, 2021 ยท 2:38 AM
Copy reference
Filing
8-K
Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws
Exhibits
EX-3.1
EX-3.1
EX-3.2
EX-3.2
EX-10.1
EX-10.1